Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMATREM for Hypothalamo-pituitary disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where SOMATREM was used for Hypothalamo-pituitary disorder.

Most Reported Side Effects for SOMATREM

Side Effect Reports % Deaths Hosp.
Clear cell renal cell carcinoma 51 31.3% 1 1
Lymphoproliferative disorder 51 31.3% 1 1
Off label use 46 28.2% 1 1
Product use in unapproved indication 32 19.6% 1 1
Renal cell carcinoma 25 15.3% 0 0
Drug dose omission 14 8.6% 0 5
Growth retardation 14 8.6% 0 2
Malaise 14 8.6% 0 9
Seizure 11 6.8% 1 3
Hair follicle tumour benign 10 6.1% 1 1
Pain 10 6.1% 0 2
Off label use of device 9 5.5% 0 0
Pyrexia 9 5.5% 1 5
Weight increased 9 5.5% 0 2
Headache 8 4.9% 0 5

Other Indications for SOMATREM

Product used for unknown indication (58) Growth hormone deficiency (42) Dwarfism (35) Hypopituitarism (22) Body height below normal (7) Turner's syndrome (7)

Other Drugs Used for Hypothalamo-pituitary disorder

SOMATROPIN (633) PEGVISOMANT (41) HYDROCORTISONE (25) DEXTROAMPHETAMINE (22) CETRORELIX (17) LANREOTIDE (11) OCTREOTIDE (11) FOLLITROPIN BETA (10) LEUPROLIDE (10) TESTOSTERONE (8)

Related Pages

SOMATREM Full Profile All Hypothalamo-pituitary disorder Drugs SOMATREM Demographics SOMATREM Timeline